Effect of Sarcopenia in Stroke Patients

Effect of Sarcopenia in Stroke Patients

Primary research purpose:

-Prospective study to screen post stroke patients with sarcopenia and evaluate its effect on recovery

Secondary research purpose:

• To determine the degree of sarcopenia and correlation with poor functional prognosis of stroke in the stroke patient group.
• To determine the degree of sarcopenia and correlation with dixon MRI of thigh muscle
• To evaluate surface EMG (SEMG)-based signals and correlation with sarcopenia
• To determine the degree of sarcopenia and correlation with brain morphometric changes

Patients with first-ever stroke will be enrolled and assessed for sarcopenia. The evaluation parameters will include standard sarcopenia parameters and also SEMG-based signals and imaging studies.

Inclusion Criteria:

• Patients 65 years of age or older, stroke patients with first onset within 4 weeks

Exclusion Criteria:

• Patients who have not been evaluated for sarcopenia
• Patients with neuromuscular diseases other than stroke that may affect gait function
• Patients unable to conduct clinical trials according to instructions
• Patients with uncontrolled medical/surgical disease
• Patients with metal substances in the body such as cardiac pacemakers, cochlear implants, etc.
• Patients who have difficulty collecting blood
• Patients who are difficult to follow up after 6 months of onset due to moving to another area
• Patients who have Parkinson's disease, dementia, or have a history of neuromuscular diseases such as Guillain-Barré syndrome or myasthenia gravis